Back To: Home : Featured Technology : PCR/qPCR

CLICK HERE FOR WHAT'S NEW IN:
 

Receptos, Ono to collaborate on GPCR target
February 2012
SHARING OPTIONS:

SAN DIEGOŚReceptos Inc. and Ono Pharmaceuticals Co. Ltd. recently announced a research and development collaboration for the development of small-molecule modulators against an undisclosed GPCR target. Using its GPCR structure technology platform, Receptos will generate high-resolution protein crystal structures of the target to help Ono in its structure-based drug design. While specific details were not disclosed, Receptos will receive an upfront payment, research funding and development-based milestones. Ono will have worldwide exclusive rights for the development and sale of any product containing a compound that results from the collaboration.  
 
Dr. Kazuhito Kawabata, executive officer and executive director of discovery and research for Ono, noted in a press release that, "Receptos' GPCR protein crystal structure determination platform technology is highly regarded by Ono."
 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.